The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on October 23, 2014, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • lonnie: So pleased to have found this forum. I don’t need to share my experience with a bona fide commitment...
  • Rachel: Thank for your honest post. I can relate to some of it. It did help when I met and married the most wonderful...
  • depresseddivorcee: I’m very depressed at the moment. I have therpy and doctors. I jsut mis smy ex husband so...
  • Mia: wow. ive stumbled across pyschcentral a few times and i remember feeling like the articles were misinformed...
  • Nemya: Thank you so much for this article. It’s very concise and an easy read for those that have...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code